Southern Africa Litigation Centre launches HIV/AIDS program

The Southern Africa Litigation Centre on Monday announced the launch of a new program that will focus on human rights in an effort to address HIV/AIDS issues in the region, the SAPA/SABCNews.com reports.

Program Director Priti Patel said the program recognizes the importance of a human rights approach to curb the spread and mitigate the effects of HIV on individuals and communities in the region.

Patel added that the program seeks to work with and support local and regional lawyers, community groups and other civil society members by bringing court cases on HIV/AIDS-related issues -- including discrimination, access to treatment and mandatory testing (SAPA/SABCNews.com, 10/29).

According to Patel, the program "does not intend to duplicate the groundbreaking work" being done by local, national and regional organizations on these issues.

It will "aim to bolster" the work of local and other regional groups to increase the use of the law and litigation to "advocate for the rights of those living with HIV and those rendered vulnerable by the pandemic" (SALC release, 10/29).

Patel said that although the law is a "powerful advocacy tool" for upholding the rights of people living with and affected by HIV/AIDS, there is a "dearth of cases in national courts on HIV/AIDS-related issues" in most Southern African countries (SAPA/SABCNews.com, 10/29).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus